Uppsala, Sweden

Bengt L Lindqvist

USPTO Granted Patents = 11 

Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 237(Granted Patents)


Location History:

  • Upsala, SE (1989)
  • Myskdalen, SE (1994)
  • Uppsala, SE (1987 - 2023)

Company Filing History:


Years Active: 1987-2023

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Bengt L Lindqvist

Introduction

Bengt L Lindqvist is a notable inventor based in Uppsala, Sweden, with an impressive portfolio of 11 patents to his name. His work primarily focuses on biopharmaceutical applications, particularly in the development of hyaluronan conjugates with pharmaceutically active substances. Lindqvist's contributions have significant implications for treatment methodologies in both human and veterinary medicine.

Latest Patents

One of Lindqvist's latest patents involves a method for manufacturing a hyaluronan conjugate. This process entails providing hyaluronan in solution or gel form and subsequently reacting it with an anhydride reagent. This reaction produces a hyaluronan hemi-ester with a defined chain length between the hyaluronan and the ester group. The final product is a hyaluronan conjugate that possesses free hemi-ester groups, enabling the binding of a pharmaceutically active compound. The resulting conjugate is not only innovative but also suitable for various treatment methods in medical practice.

Career Highlights

Throughout his career, Bengt L Lindqvist has worked with prominent companies in the pharmaceutical sector. He has been associated with Pharmacia AB and Synartro AB, where he has likely collaborated with leading experts in the industry. His contributions in these roles are pivotal in shaping the current landscape of pharmaceutical innovations.

Collaborations

Lindqvist has partnered with several notable coworkers, including Rune Ringom and Tomas Malson. Their collaborative efforts have helped drive the progress of research and development in their respective fields, enhancing the potential of biopharmaceutical applications.

Conclusion

In conclusion, Bengt L Lindqvist stands out as a significant inventor in the realm of biopharmaceutical products. His innovative patents and collaborative career reflect his commitment to advancing medical treatments through the application of hyaluronan-based technologies. As the field continues to evolve, Lindqvist's contributions will undoubtedly play a crucial role in future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…